尼美舒利舒林酸对人胃癌细胞NF-κBiNOS表达的抑制作用

Inhibitory Effect of Nimesulide and Sulindac on the Expression of NF-κ B and iNOS in Human Gastric Carcinoma SGC-7901 Cells

  • 摘要: 目的:观察尼美舒利、舒林酸对人胃癌SGC-7901细胞NF-κB、iNOS表达的影响,初步探讨其在NSAIDs抗肿瘤作用中的意义。方法:对人胃癌SGC-7901细胞进行细胞培养,采用免疫组织化学PowervisionTM两步法、westernblot方法检测不同浓度尼美舒利、舒林酸作用后细胞NF-κB、iNOS表达情况;同时生化方法检测细胞内TNOS、iNOS、NO含量的改变。结果:与阴性对照组相比,药物干预48h后尼美舒利100、200μmol/L组,舒林酸0.6、1.2mmol/L组人胃癌SGC-7901细胞NF-κB、iNOS蛋白表达率及细胞内TNOS、iNOS、NO含量明显降低(P<0.05),并且iNOS,NF-κB之间呈正相关性(P<0.05)。结论:尼美舒利、舒林酸可以通过抑制人胃癌细胞NF-κB、iNOS的蛋白表达而发挥抗肿瘤作用。抑制iNOS的表达对NF-κB的抑制作用有关。

     

    Abstract: Objective: To detect the effect of nimesulide and Sulindac on the expression of iNOS, NF-κ B and to explore the significance of this effect in the antitumor process of NSAIDs. Methods: SGC-7901 cells were cultured in different concentrations of nimesulide and sulindac for about 48 h and the expression of iNOS and NF-κ B in tumor cell was detected with Power visionTM immunohistochemical method and western-blot analysis, while the content of TNOS、iNOS、NO in SGC-7901 cells was detected by biochemistry method, respectively. Results: Compared to the negative control group, the expression rate of NF-κ B, iNOS and the content of TNOS, iNOS, NO in 100, 200μmol/L nimesulide and 0.6, 1.2mmol/L Sulindac group were significantly decreased (P<0.05). There was a positive correlationship between the expression of NF-κ B and of iNOS. Conclusions: Nimesulide and sulindac show the inhibitory effects on the expression of NF-κ B and iNOS in human gastric carcinoma SGC7901 cells and this may play some roles in the anti-tumor process of Sulindac and nimesulide. Inhibition of the expression of iNOS may result in the inhibitory effect on NF-κ B.

     

/

返回文章
返回